×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NASDAQ:UTMD

Utah Medical Products Stock Forecast, Price & News

$86.97
+2.07 (+2.44%)
(As of 06/24/2022 04:00 PM ET)
Add
Compare
Today's Range
$83.52
$87.50
50-Day Range
$81.49
$89.09
52-Week Range
$80.31
$133.87
Volume
72,155 shs
Average Volume
9,930 shs
Market Capitalization
$316.57 million
P/E Ratio
20.81
Dividend Yield
1.33%
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

UTMD Stock Forecast (MarketRank)

Overall MarketRank

1.63 out of 5 stars

Medical Sector

947th out of 1,417 stocks

Surgical & Medical Instruments Industry

101st out of 138 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -
Utah Medical Products logo

About Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

UTMD Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:UTMD
CUSIP
91748810
Employees
178
Year Founded
N/A

Company Calendar

Ex-Dividend for 4/5 Dividend
3/17/2022
Dividend Payable
4/05/2022
Last Earnings
4/26/2022
Ex-Dividend for 7/6 Dividend
6/16/2022
Today
6/26/2022
Dividend Payable
7/06/2022
Next Earnings (Estimated)
7/28/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$14.79 million
Pretax Margin
39.06%

Debt

Sales & Book Value

Annual Sales
$49.05 million
Cash Flow
$6.15 per share
Book Value
$29.34 per share

Miscellaneous

Free Float
3,404,000
Market Cap
$316.57 million
Optionable
Not Optionable
Beta
0.24














Utah Medical Products Frequently Asked Questions

How has Utah Medical Products' stock performed in 2022?

Utah Medical Products' stock was trading at $100.00 at the beginning of 2022. Since then, UTMD shares have decreased by 13.0% and is now trading at $86.97.
View the best growth stocks for 2022 here
.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022.
View our earnings forecast for Utah Medical Products
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) issued its quarterly earnings data on Tuesday, April, 26th. The medical instruments supplier reported $0.96 EPS for the quarter. The medical instruments supplier had revenue of $12.32 million for the quarter. Utah Medical Products had a trailing twelve-month return on equity of 14.11% and a net margin of 30.34%.
View Utah Medical Products' earnings history
.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a quarterly dividend on Tuesday, May 10th. Investors of record on Friday, June 17th will be paid a dividend of $0.29 per share on Wednesday, July 6th. This represents a $1.16 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend is Thursday, June 16th.
View Utah Medical Products' dividend history
.

Is Utah Medical Products a good dividend stock?

Utah Medical Products(NASDAQ:UTMD) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.33%. Utah Medical Products does not yet have a strong track record of dividend growth. The dividend payout ratio of Utah Medical Products is 27.75%. This payout ratio is at a healthy, sustainable level, below 75%.
View Utah Medical Products' dividend history.

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 75, Pay $494.21k)
  • Mr. Brian L. Koopman, Principal Financial Officer, Accounting Mang. & Controller (Age 52, Pay $131.84k)
  • Mark L. Fox, VP of Marketing

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?

8 employees have rated Utah Medical Products CEO Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among Utah Medical Products' employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and (AAXN).

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (6.12%), BlackRock Inc. (5.83%), Vanguard Group Inc. (4.55%), Dimensional Fund Advisors LP (4.10%), Rice Hall James & Associates LLC (3.20%) and Rice Hall James & Associates LLC (2.86%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Barbara A Payne, Brian Koopman, Ernst G Hoyer and Kevin L Cornwell.
View institutional ownership trends for Utah Medical Products
.

Which major investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Rice Hall James & Associates LLC, Goldman Sachs Group Inc., BlackRock Inc., Invesco Ltd., Loomis Sayles & Co. L P, Northern Trust Corp, and BNP Paribas Arbitrage SA. Company insiders that have sold Utah Medical Products company stock in the last two years include Barbara A Payne, and Ernst G Hoyer.
View insider buying and selling activity for Utah Medical Products
or view top insider-selling stocks.

Which major investors are buying Utah Medical Products stock?

UTMD stock was acquired by a variety of institutional investors in the last quarter, including HealthInvest Partners AB, JPMorgan Chase & Co., Ancora Advisors LLC, LSV Asset Management, James Investment Research Inc., Annex Advisory Services LLC, Russell Investments Group Ltd., and Rice Hall James & Associates LLC.
View insider buying and selling activity for Utah Medical Products
or or view top insider-buying stocks.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $86.97.

How much money does Utah Medical Products make?

Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $316.57 million and generates $49.05 million in revenue each year. The medical instruments supplier earns $14.79 million in net income (profit) each year or $4.179990 on an earnings per share basis.

How many employees does Utah Medical Products have?

Utah Medical Products employs 178 workers across the globe.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The official website for Utah Medical Products is www.utahmed.com. The medical instruments supplier can be reached via phone at (801) 566-1200 or via fax at 801-566-7305.

This page (NASDAQ:UTMD) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.